Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.95301505 |
2 | thrombin receptor signaling pathway (GO:0070493) | 5.70841408 |
3 | protein neddylation (GO:0045116) | 5.27330415 |
4 | neutrophil activation involved in immune response (GO:0002283) | 4.85578621 |
5 | positive regulation of mast cell activation (GO:0033005) | 4.72206449 |
6 | platelet dense granule organization (GO:0060155) | 4.49915641 |
7 | positive regulation of interferon-alpha production (GO:0032727) | 4.40302039 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.34047735 |
9 | modulation by symbiont of host defense response (GO:0052031) | 4.34047735 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.34047735 |
11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.34047735 |
12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.34047735 |
13 | modulation by symbiont of host immune response (GO:0052553) | 4.34047735 |
14 | regulation of interferon-alpha production (GO:0032647) | 4.13359016 |
15 | regulation of platelet aggregation (GO:0090330) | 4.03222325 |
16 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.03125508 |
17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.95249152 |
18 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.94426289 |
19 | positive regulation of mast cell degranulation (GO:0043306) | 3.94426289 |
20 | regulation of platelet activation (GO:0010543) | 3.86258551 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80212476 |
22 | response to peptidoglycan (GO:0032494) | 3.69819838 |
23 | positive regulation of B cell differentiation (GO:0045579) | 3.68917089 |
24 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.62541312 |
25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60853499 |
26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60853499 |
27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57403150 |
28 | cellular response to zinc ion (GO:0071294) | 3.53839468 |
29 | detection of molecule of bacterial origin (GO:0032490) | 3.49986315 |
30 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.43764465 |
31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.41220779 |
32 | response to host immune response (GO:0052572) | 3.41220779 |
33 | response to interferon-alpha (GO:0035455) | 3.40592923 |
34 | sequestering of actin monomers (GO:0042989) | 3.38836605 |
35 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.33584062 |
36 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.32207037 |
37 | positive regulation of macrophage cytokine production (GO:0060907) | 3.27208075 |
38 | negative regulation of neurotransmitter transport (GO:0051589) | 3.27128889 |
39 | negative regulation of interleukin-17 production (GO:0032700) | 3.26848886 |
40 | negative regulation of mast cell activation (GO:0033004) | 3.26427220 |
41 | phagocytosis, engulfment (GO:0006911) | 3.26163696 |
42 | regulation of mast cell degranulation (GO:0043304) | 3.25777528 |
43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.24327230 |
44 | positive regulation of granulocyte differentiation (GO:0030854) | 3.23031945 |
45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23000697 |
46 | B cell mediated immunity (GO:0019724) | 3.22739158 |
47 | macrophage activation involved in immune response (GO:0002281) | 3.22587417 |
48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.21456994 |
49 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.18690216 |
50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.17693089 |
51 | neutrophil activation (GO:0042119) | 3.17356699 |
52 | negative regulation of phagocytosis (GO:0050765) | 3.15896435 |
53 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.14381950 |
54 | respiratory burst (GO:0045730) | 3.07492035 |
55 | granulocyte activation (GO:0036230) | 3.07250347 |
56 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.05692037 |
57 | immunoglobulin mediated immune response (GO:0016064) | 3.05434361 |
58 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.04317356 |
59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03396543 |
60 | response to host (GO:0075136) | 3.03396543 |
61 | response to host defenses (GO:0052200) | 3.03396543 |
62 | T-helper 1 type immune response (GO:0042088) | 3.01964738 |
63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00608382 |
64 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.99837618 |
65 | cellular extravasation (GO:0045123) | 2.98991559 |
66 | regulation of T cell chemotaxis (GO:0010819) | 2.97814524 |
67 | positive regulation of T cell chemotaxis (GO:0010820) | 2.97814524 |
68 | negative regulation of viral genome replication (GO:0045071) | 2.97040090 |
69 | positive regulation of macrophage differentiation (GO:0045651) | 2.94750756 |
70 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.94501829 |
71 | response to type I interferon (GO:0034340) | 2.93531078 |
72 | cellular response to type I interferon (GO:0071357) | 2.93530411 |
73 | type I interferon signaling pathway (GO:0060337) | 2.93530411 |
74 | regulation of chemokine biosynthetic process (GO:0045073) | 2.90752317 |
75 | defense response to protozoan (GO:0042832) | 2.90129245 |
76 | regulation of interleukin-17 production (GO:0032660) | 2.89841698 |
77 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.88987152 |
78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.88986090 |
79 | positive regulation of interleukin-12 production (GO:0032735) | 2.88957489 |
80 | response to interferon-beta (GO:0035456) | 2.88284402 |
81 | regulation of mononuclear cell migration (GO:0071675) | 2.88063515 |
82 | myeloid dendritic cell activation (GO:0001773) | 2.87859185 |
83 | positive regulation of interferon-beta production (GO:0032728) | 2.86240722 |
84 | leukocyte degranulation (GO:0043299) | 2.86128299 |
85 | megakaryocyte development (GO:0035855) | 2.85371478 |
86 | regulation of macrophage cytokine production (GO:0010935) | 2.83914954 |
87 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.83754459 |
88 | positive regulation of vasculogenesis (GO:2001214) | 2.81266991 |
89 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.80869749 |
90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.80607141 |
91 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.80475005 |
92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78957832 |
93 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.78145690 |
94 | regulation of monocyte chemotaxis (GO:0090025) | 2.77936697 |
95 | positive regulation of antigen processing and presentation (GO:0002579) | 2.77280337 |
96 | adenosine metabolic process (GO:0046085) | 2.75992154 |
97 | relaxation of smooth muscle (GO:0044557) | 2.74552929 |
98 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.74439341 |
99 | actin nucleation (GO:0045010) | 2.73298667 |
100 | cellular response to exogenous dsRNA (GO:0071360) | 2.73055150 |
101 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.71978389 |
102 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.71881608 |
103 | negative regulation of lipid storage (GO:0010888) | 2.71338156 |
104 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70213705 |
105 | positive regulation of T cell migration (GO:2000406) | 2.69670130 |
106 | myeloid dendritic cell differentiation (GO:0043011) | 2.68303393 |
107 | reactive oxygen species biosynthetic process (GO:1903409) | 2.68117754 |
108 | cellular response to interferon-beta (GO:0035458) | 2.67612872 |
109 | mast cell activation (GO:0045576) | 2.66656874 |
110 | positive regulation of chemokine production (GO:0032722) | 2.66656270 |
111 | lipoxygenase pathway (GO:0019372) | 2.65251408 |
112 | response to muramyl dipeptide (GO:0032495) | 2.65112614 |
113 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.64858540 |
114 | regulation of hypersensitivity (GO:0002883) | 2.64364608 |
115 | superoxide anion generation (GO:0042554) | 2.64009697 |
116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.63729087 |
117 | myeloid cell activation involved in immune response (GO:0002275) | 2.63496900 |
118 | microglial cell activation (GO:0001774) | 2.63084293 |
119 | purinergic receptor signaling pathway (GO:0035587) | 2.62999116 |
120 | response to protozoan (GO:0001562) | 2.62844265 |
121 | natural killer cell mediated immunity (GO:0002228) | 2.62632152 |
122 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.62632152 |
123 | regulation of B cell differentiation (GO:0045577) | 2.62001362 |
124 | secretory granule organization (GO:0033363) | 2.61632978 |
125 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.60903285 |
126 | regulation of cholesterol storage (GO:0010885) | 2.59726002 |
127 | adenosine receptor signaling pathway (GO:0001973) | 2.58870830 |
128 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.58361668 |
129 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.58025034 |
130 | macrophage activation (GO:0042116) | 2.57971585 |
131 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.57666785 |
132 | signal peptide processing (GO:0006465) | 2.57441082 |
133 | cell adhesion mediated by integrin (GO:0033627) | 2.57096597 |
134 | negative regulation of heart rate (GO:0010459) | 2.56705833 |
135 | positive regulation of lymphocyte migration (GO:2000403) | 2.56688534 |
136 | negative regulation of interleukin-12 production (GO:0032695) | 2.56321407 |
137 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.55492073 |
138 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.54443895 |
139 | detection of external biotic stimulus (GO:0098581) | 2.53887395 |
140 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.53419303 |
141 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.53246840 |
142 | purine-containing compound salvage (GO:0043101) | 2.53042121 |
143 | peptide catabolic process (GO:0043171) | 2.52659420 |
144 | histamine secretion (GO:0001821) | 2.52161790 |
145 | regulation of cellular extravasation (GO:0002691) | 2.50461519 |
146 | endosome to melanosome transport (GO:0035646) | 2.49989009 |
147 | endosome to pigment granule transport (GO:0043485) | 2.49989009 |
148 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.49471851 |
149 | cell wall macromolecule catabolic process (GO:0016998) | 2.49433130 |
150 | regulation of antigen processing and presentation (GO:0002577) | 2.48938046 |
151 | regulation of mast cell activation (GO:0033003) | 2.48917979 |
152 | positive regulation of type 2 immune response (GO:0002830) | 2.48904815 |
153 | myeloid leukocyte activation (GO:0002274) | 2.48800410 |
154 | dendritic cell differentiation (GO:0097028) | 2.48253039 |
155 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.48078337 |
156 | membrane invagination (GO:0010324) | 2.47888443 |
157 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.47273682 |
158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45730254 |
159 | monoamine transport (GO:0015844) | 2.45136815 |
160 | negative regulation of appetite (GO:0032099) | 2.43878016 |
161 | negative regulation of response to food (GO:0032096) | 2.43878016 |
162 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.42998020 |
163 | regulation of memory T cell differentiation (GO:0043380) | 2.42683551 |
164 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.41219024 |
165 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.41219024 |
166 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.41054118 |
167 | negative regulation of platelet activation (GO:0010544) | 2.40331114 |
168 | positive regulation of leukocyte degranulation (GO:0043302) | 2.39503445 |
169 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.39192202 |
170 | detection of other organism (GO:0098543) | 2.38486690 |
171 | positive regulation of interleukin-17 production (GO:0032740) | 2.38363913 |
172 | positive regulation of B cell mediated immunity (GO:0002714) | 2.37877350 |
173 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.37877350 |
174 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37761929 |
175 | xenobiotic catabolic process (GO:0042178) | 2.36732466 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.30701775 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.54011425 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.31171220 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.42136262 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.06604488 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.63311930 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.57832632 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40397992 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.14489780 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09749015 |
11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.00537720 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90151601 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78631065 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62152866 |
15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.46261617 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44903970 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43691539 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32484609 |
19 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.19090010 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12277472 |
21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.08019549 |
22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07853075 |
23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.07337584 |
24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06905622 |
25 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.05595901 |
26 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.05595901 |
27 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.01112440 |
28 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00276968 |
29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98310964 |
30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92748797 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86436779 |
32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84314048 |
33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82533485 |
34 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.81913041 |
35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.81491952 |
36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81124747 |
37 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.76923429 |
38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75619120 |
39 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.72758919 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72298311 |
41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71376877 |
42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70812591 |
43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70200410 |
44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70038176 |
45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.66398522 |
46 | CJUN_26792858_Chip-Seq_BT549_Human | 1.64579014 |
47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64295618 |
48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64086177 |
49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.61706698 |
50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59108102 |
51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58346669 |
52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56803528 |
53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52499778 |
54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51666845 |
55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51646316 |
56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50495225 |
57 | MYB_26560356_Chip-Seq_TH2_Human | 1.45688701 |
58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43395791 |
59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41982031 |
60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41673927 |
61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37099632 |
62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37020453 |
63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36382021 |
64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.35856256 |
65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33267369 |
66 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32928928 |
67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32176622 |
68 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.31672641 |
69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31424601 |
70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29893967 |
71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28826155 |
72 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28496742 |
73 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.27246221 |
74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26961650 |
75 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26110129 |
76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25487662 |
77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25378988 |
78 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.23324704 |
79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23142560 |
80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22903961 |
81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22903961 |
82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22636584 |
83 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21561524 |
84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21311383 |
85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21042702 |
86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20771429 |
87 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18946927 |
88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17824371 |
89 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17595246 |
90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17095448 |
91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16685964 |
92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16436213 |
93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15676299 |
94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15255399 |
95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14483949 |
96 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13670631 |
97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13200521 |
98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12983973 |
99 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12983973 |
100 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12735962 |
101 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11953773 |
102 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09849424 |
103 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08917088 |
104 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07290699 |
105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06593481 |
106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05910224 |
107 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05608035 |
108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05534821 |
109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05450809 |
110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04514546 |
111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03524963 |
112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02548531 |
113 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02010035 |
114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01756677 |
115 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01739296 |
116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01485170 |
117 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00884701 |
118 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00533305 |
119 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00103959 |
120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99884652 |
121 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99692540 |
122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99138678 |
123 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98736068 |
124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98706203 |
125 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98678320 |
126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97946310 |
127 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96927250 |
128 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96195650 |
129 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95750784 |
130 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94682520 |
131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91159372 |
132 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.90797675 |
133 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88592850 |
134 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88503833 |
135 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87322389 |
136 | MYB_26560356_Chip-Seq_TH1_Human | 0.87144052 |
137 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83639571 |
138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81356773 |
139 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79948984 |
140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79671617 |
141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78867153 |
142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78026471 |
143 | P300_19829295_ChIP-Seq_ESCs_Human | 0.77016051 |
144 | MAF_26560356_Chip-Seq_TH1_Human | 0.76490753 |
145 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.76095738 |
146 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72457089 |
147 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72340122 |
148 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71916126 |
149 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.71819956 |
150 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71262065 |
151 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.71140128 |
152 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70008790 |
153 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.69496085 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.33367960 |
2 | MP0008438_abnormal_cutaneous_collagen | 3.85699682 |
3 | MP0003724_increased_susceptibility_to | 3.30332310 |
4 | MP0009785_altered_susceptibility_to | 3.15433437 |
5 | MP0002148_abnormal_hypersensitivity_rea | 2.97817527 |
6 | MP0003436_decreased_susceptibility_to | 2.84553330 |
7 | MP0008004_abnormal_stomach_pH | 2.52311943 |
8 | MP0006054_spinal_hemorrhage | 2.50413689 |
9 | MP0002419_abnormal_innate_immunity | 2.46284928 |
10 | MP0001879_abnormal_lymphatic_vessel | 2.40069868 |
11 | MP0005000_abnormal_immune_tolerance | 2.27972012 |
12 | MP0005025_abnormal_response_to | 2.12127786 |
13 | MP0005503_abnormal_tendon_morphology | 2.10500355 |
14 | MP0001790_abnormal_immune_system | 2.06214406 |
15 | MP0005387_immune_system_phenotype | 2.06214406 |
16 | MP0000685_abnormal_immune_system | 2.05868645 |
17 | MP0006082_CNS_inflammation | 2.01764504 |
18 | MP0002166_altered_tumor_susceptibility | 2.01641020 |
19 | MP0001533_abnormal_skeleton_physiology | 1.97165984 |
20 | MP0002452_abnormal_antigen_presenting | 1.94468387 |
21 | MP0002006_tumorigenesis | 1.92947635 |
22 | MP0003303_peritoneal_inflammation | 1.89686923 |
23 | MP0001958_emphysema | 1.89343031 |
24 | MP0003279_aneurysm | 1.87632424 |
25 | MP0005671_abnormal_response_to | 1.85084838 |
26 | MP0005275_abnormal_skin_tensile | 1.80392709 |
27 | MP0009764_decreased_sensitivity_to | 1.77611498 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.75107408 |
29 | MP0000343_altered_response_to | 1.67642370 |
30 | MP0004782_abnormal_surfactant_physiolog | 1.65162779 |
31 | MP0003172_abnormal_lysosome_physiology | 1.62837425 |
32 | MP0001853_heart_inflammation | 1.61093021 |
33 | MP0001819_abnormal_immune_cell | 1.60586079 |
34 | MP0002723_abnormal_immune_serum | 1.60555131 |
35 | MP0010368_abnormal_lymphatic_system | 1.60371059 |
36 | MP0002420_abnormal_adaptive_immunity | 1.56732286 |
37 | MP0001800_abnormal_humoral_immune | 1.55828482 |
38 | MP0003448_altered_tumor_morphology | 1.54395582 |
39 | MP0005464_abnormal_platelet_physiology | 1.53964982 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.48996296 |
41 | MP0000858_altered_metastatic_potential | 1.48445655 |
42 | MP0000569_abnormal_digit_pigmentation | 1.46471714 |
43 | MP0005164_abnormal_response_to | 1.45307940 |
44 | MP0002998_abnormal_bone_remodeling | 1.44549483 |
45 | MP0005058_abnormal_lysosome_morphology | 1.44044430 |
46 | MP0000767_abnormal_smooth_muscle | 1.43363585 |
47 | MP0001845_abnormal_inflammatory_respons | 1.43221857 |
48 | MP0004883_abnormal_blood_vessel | 1.42025581 |
49 | MP0005397_hematopoietic_system_phenotyp | 1.39238427 |
50 | MP0001545_abnormal_hematopoietic_system | 1.39238427 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 1.39191240 |
52 | MP0003186_abnormal_redox_activity | 1.37994254 |
53 | MP0003828_pulmonary_edema | 1.32682804 |
54 | MP0002405_respiratory_system_inflammati | 1.31653219 |
55 | MP0010386_abnormal_urinary_bladder | 1.31565414 |
56 | MP0005390_skeleton_phenotype | 1.31560694 |
57 | MP0001851_eye_inflammation | 1.29321622 |
58 | MP0001542_abnormal_bone_strength | 1.29023192 |
59 | MP0000230_abnormal_systemic_arterial | 1.25178538 |
60 | MP0002009_preneoplasia | 1.23253774 |
61 | MP0004147_increased_porphyrin_level | 1.23004652 |
62 | MP0008469_abnormal_protein_level | 1.22136197 |
63 | MP0005075_abnormal_melanosome_morpholog | 1.21039625 |
64 | MP0010155_abnormal_intestine_physiology | 1.18678726 |
65 | MP0002295_abnormal_pulmonary_circulatio | 1.16807652 |
66 | MP0002138_abnormal_hepatobiliary_system | 1.16573833 |
67 | MP0004272_abnormal_basement_membrane | 1.16215464 |
68 | MP0004808_abnormal_hematopoietic_stem | 1.16060606 |
69 | MP0005174_abnormal_tail_pigmentation | 1.13234866 |
70 | MP0002876_abnormal_thyroid_physiology | 1.13231485 |
71 | MP0002132_abnormal_respiratory_system | 1.12108675 |
72 | MP0000249_abnormal_blood_vessel | 1.11374023 |
73 | MP0009278_abnormal_bone_marrow | 1.10919056 |
74 | MP0000681_abnormal_thyroid_gland | 1.10606354 |
75 | MP0003300_gastrointestinal_ulcer | 1.09692486 |
76 | MP0000716_abnormal_immune_system | 1.09461622 |
77 | MP0002722_abnormal_immune_system | 1.07807251 |
78 | MP0003075_altered_response_to | 1.07806271 |
79 | MP0001986_abnormal_taste_sensitivity | 1.06066228 |
80 | MP0005646_abnormal_pituitary_gland | 1.05520362 |
81 | MP0010352_gastrointestinal_tract_polyps | 1.04640886 |
82 | MP0002877_abnormal_melanocyte_morpholog | 1.03444094 |
83 | MP0005084_abnormal_gallbladder_morpholo | 1.01728384 |
84 | MP0003011_delayed_dark_adaptation | 1.00790967 |
85 | MP0002398_abnormal_bone_marrow | 1.00507029 |
86 | MP0000465_gastrointestinal_hemorrhage | 1.00022647 |
87 | MP0009765_abnormal_xenobiotic_induced | 0.99367655 |
88 | MP0003091_abnormal_cell_migration | 0.99273115 |
89 | MP0004084_abnormal_cardiac_muscle | 0.98231217 |
90 | MP0005166_decreased_susceptibility_to | 0.97892172 |
91 | MP0003787_abnormal_imprinting | 0.96040645 |
92 | MP0002736_abnormal_nociception_after | 0.92025968 |
93 | MP0002396_abnormal_hematopoietic_system | 0.91157800 |
94 | MP0001915_intracranial_hemorrhage | 0.91023068 |
95 | MP0001663_abnormal_digestive_system | 0.90324633 |
96 | MP0002933_joint_inflammation | 0.90184609 |
97 | MP0005253_abnormal_eye_physiology | 0.89879086 |
98 | MP0002282_abnormal_trachea_morphology | 0.89380861 |
99 | MP0008789_abnormal_olfactory_epithelium | 0.89198547 |
100 | MP0009384_cardiac_valve_regurgitation | 0.89141360 |
101 | MP0003943_abnormal_hepatobiliary_system | 0.89112510 |
102 | MP0000015_abnormal_ear_pigmentation | 0.88109701 |
103 | MP0004510_myositis | 0.87182300 |
104 | MP0003795_abnormal_bone_structure | 0.87180122 |
105 | MP0002429_abnormal_blood_cell | 0.87144622 |
106 | MP0006072_abnormal_retinal_apoptosis | 0.86037998 |
107 | MP0001764_abnormal_homeostasis | 0.84898978 |
108 | MP0009763_increased_sensitivity_to | 0.82948356 |
109 | MP0000516_abnormal_urinary_system | 0.82796390 |
110 | MP0005367_renal/urinary_system_phenotyp | 0.82796390 |
111 | MP0009697_abnormal_copulation | 0.82627883 |
112 | MP0002133_abnormal_respiratory_system | 0.81245538 |
113 | MP0005388_respiratory_system_phenotype | 0.81245538 |
114 | MP0005167_abnormal_blood-brain_barrier | 0.80593068 |
115 | MP0000689_abnormal_spleen_morphology | 0.79392648 |
116 | MP0005076_abnormal_cell_differentiation | 0.77322987 |
117 | MP0005535_abnormal_body_temperature | 0.77146206 |
118 | MP0004484_altered_response_of | 0.76303337 |
119 | MP0002928_abnormal_bile_duct | 0.75108602 |
120 | MP0005410_abnormal_fertilization | 0.74982010 |
121 | MP0003183_abnormal_peptide_metabolism | 0.74933209 |
122 | MP0003638_abnormal_response/metabolism_ | 0.74642237 |
123 | MP0005197_abnormal_uvea_morphology | 0.74430069 |
124 | MP0003880_abnormal_central_pattern | 0.74263096 |
125 | MP0009333_abnormal_splenocyte_physiolog | 0.73774560 |
126 | MP0009115_abnormal_fat_cell | 0.73547829 |
127 | MP0008872_abnormal_physiological_respon | 0.72085486 |
128 | MP0002113_abnormal_skeleton_development | 0.71318185 |
129 | MP0008775_abnormal_heart_ventricle | 0.71113537 |
130 | MP0002163_abnormal_gland_morphology | 0.70726082 |
131 | MP0004947_skin_inflammation | 0.70423358 |
132 | MP0003252_abnormal_bile_duct | 0.69841441 |
133 | MP0002102_abnormal_ear_morphology | 0.69298110 |
134 | MP0005165_increased_susceptibility_to | 0.69169173 |
135 | MP0002090_abnormal_vision | 0.69141374 |
136 | MP0000372_irregular_coat_pigmentation | 0.68864940 |
137 | MP0003866_abnormal_defecation | 0.68823459 |
138 | MP0003763_abnormal_thymus_physiology | 0.67721796 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged bleeding time (HP:0003010) | 6.19033540 |
2 | Recurrent abscess formation (HP:0002722) | 4.92882114 |
3 | Eczematoid dermatitis (HP:0000976) | 4.73122166 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.68511589 |
5 | Increased mean platelet volume (HP:0011877) | 4.58921450 |
6 | Abnormal platelet volume (HP:0011876) | 4.56288731 |
7 | Recurrent bacterial skin infections (HP:0005406) | 4.44157583 |
8 | Epistaxis (HP:0000421) | 4.30921525 |
9 | Stomatitis (HP:0010280) | 4.25386932 |
10 | Menorrhagia (HP:0000132) | 3.74899884 |
11 | Gingival bleeding (HP:0000225) | 3.72645999 |
12 | Myositis (HP:0100614) | 3.60287050 |
13 | Autoimmune thrombocytopenia (HP:0001973) | 3.45140871 |
14 | Vacuolated lymphocytes (HP:0001922) | 3.43436461 |
15 | Orchitis (HP:0100796) | 3.33298331 |
16 | Systemic lupus erythematosus (HP:0002725) | 3.32570052 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31440386 |
18 | Dyschromatopsia (HP:0007641) | 3.22149029 |
19 | Hematochezia (HP:0002573) | 3.14826336 |
20 | Spinal cord lesions (HP:0100561) | 3.12687090 |
21 | Syringomyelia (HP:0003396) | 3.12687090 |
22 | Mediastinal lymphadenopathy (HP:0100721) | 3.12238229 |
23 | Optic neuritis (HP:0100653) | 3.03656996 |
24 | Retrobulbar optic neuritis (HP:0100654) | 3.03656996 |
25 | Increased cerebral lipofuscin (HP:0011813) | 2.97750640 |
26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.95423239 |
27 | Abnormality of macrophages (HP:0004311) | 2.92494360 |
28 | Asymmetry of the thorax (HP:0001555) | 2.92275114 |
29 | Osteolytic defects of the hand bones (HP:0009699) | 2.90780881 |
30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.90780881 |
31 | Impaired platelet aggregation (HP:0003540) | 2.88888777 |
32 | Abnormal platelet function (HP:0011869) | 2.88888777 |
33 | Vertebral compression fractures (HP:0002953) | 2.86850684 |
34 | Aortic aneurysm (HP:0004942) | 2.83506728 |
35 | Subacute progressive viral hepatitis (HP:0006572) | 2.82779333 |
36 | Periodontitis (HP:0000704) | 2.72488003 |
37 | Panhypogammaglobulinemia (HP:0003139) | 2.65617512 |
38 | Disinhibition (HP:0000734) | 2.65599634 |
39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.65005526 |
40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.65005526 |
41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.65005526 |
42 | Vascular tortuosity (HP:0004948) | 2.64524687 |
43 | Peritonitis (HP:0002586) | 2.63015559 |
44 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.61148792 |
45 | Arterial thrombosis (HP:0004420) | 2.56120383 |
46 | Gingivitis (HP:0000230) | 2.55772830 |
47 | Interstitial pulmonary disease (HP:0006530) | 2.54694497 |
48 | Absent frontal sinuses (HP:0002688) | 2.54559204 |
49 | Spontaneous hematomas (HP:0007420) | 2.54255260 |
50 | Decreased central vision (HP:0007663) | 2.53517017 |
51 | Protrusio acetabuli (HP:0003179) | 2.51878268 |
52 | Encephalitis (HP:0002383) | 2.51688534 |
53 | Aortic dissection (HP:0002647) | 2.50949950 |
54 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.49552547 |
55 | Abolished electroretinogram (ERG) (HP:0000550) | 2.48976996 |
56 | Cellulitis (HP:0100658) | 2.45667178 |
57 | Vasculitis (HP:0002633) | 2.45411799 |
58 | Recurrent skin infections (HP:0001581) | 2.45389438 |
59 | Hepatosplenomegaly (HP:0001433) | 2.42264810 |
60 | Osteomyelitis (HP:0002754) | 2.40287878 |
61 | Conjunctival telangiectasia (HP:0000524) | 2.39267049 |
62 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.37340525 |
63 | True hermaphroditism (HP:0010459) | 2.36191755 |
64 | Basal ganglia calcification (HP:0002135) | 2.34377096 |
65 | Leukocytosis (HP:0001974) | 2.33780527 |
66 | Obstructive lung disease (HP:0006536) | 2.29600464 |
67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29600464 |
68 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.29090301 |
69 | Absent/shortened dynein arms (HP:0200106) | 2.29090301 |
70 | Myocardial infarction (HP:0001658) | 2.27732748 |
71 | Prostate neoplasm (HP:0100787) | 2.27725645 |
72 | Thrombocytosis (HP:0001894) | 2.26173911 |
73 | Abnormality of B cell number (HP:0010975) | 2.26069971 |
74 | Glomerulonephritis (HP:0000099) | 2.25583435 |
75 | 3-Methylglutaconic aciduria (HP:0003535) | 2.23871809 |
76 | Abnormality of T cell number (HP:0011839) | 2.23864374 |
77 | Mucosal telangiectasiae (HP:0100579) | 2.23258173 |
78 | Pulmonary infiltrates (HP:0002113) | 2.23203278 |
79 | T lymphocytopenia (HP:0005403) | 2.23129846 |
80 | Abnormality of lateral ventricle (HP:0030047) | 2.20658129 |
81 | Spondylolisthesis (HP:0003302) | 2.20311135 |
82 | Increased IgM level (HP:0003496) | 2.18814011 |
83 | Dilatation of the ascending aorta (HP:0005111) | 2.18635618 |
84 | Abnormal ciliary motility (HP:0012262) | 2.17829111 |
85 | Chest pain (HP:0100749) | 2.16781496 |
86 | Polyphagia (HP:0002591) | 2.15390057 |
87 | Recurrent fungal infections (HP:0002841) | 2.14889136 |
88 | Recurrent pneumonia (HP:0006532) | 2.14884793 |
89 | Abnormality of the prostate (HP:0008775) | 2.14151251 |
90 | Abnormality of the lumbar spine (HP:0100712) | 2.12931987 |
91 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12592541 |
92 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.11202883 |
93 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.11202883 |
94 | Cervical subluxation (HP:0003308) | 2.08989637 |
95 | Bone cyst (HP:0012062) | 2.08666310 |
96 | Hyperlipoproteinemia (HP:0010980) | 2.08511911 |
97 | Papilledema (HP:0001085) | 2.08118571 |
98 | Abnormality of the frontal sinuses (HP:0002687) | 2.06955672 |
99 | Eosinophilia (HP:0001880) | 2.06581481 |
100 | Viral hepatitis (HP:0006562) | 2.04663964 |
101 | Abnormality of complement system (HP:0005339) | 2.04642243 |
102 | Constricted visual fields (HP:0001133) | 2.02450505 |
103 | B lymphocytopenia (HP:0010976) | 2.01979016 |
104 | Gastrointestinal infarctions (HP:0005244) | 2.01527262 |
105 | Nephritis (HP:0000123) | 2.01093761 |
106 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00620711 |
107 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00620711 |
108 | Episodic fever (HP:0001954) | 1.98692207 |
109 | Petechiae (HP:0000967) | 1.98128136 |
110 | Medial flaring of the eyebrow (HP:0010747) | 1.97850327 |
111 | Hemoptysis (HP:0002105) | 1.96277234 |
112 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96085293 |
113 | Pulmonary artery stenosis (HP:0004415) | 1.95255356 |
114 | Pulmonary embolism (HP:0002204) | 1.94961846 |
115 | Arterial tortuosity (HP:0005116) | 1.94773587 |
116 | Mitral stenosis (HP:0001718) | 1.94672843 |
117 | Recurrent viral infections (HP:0004429) | 1.94663398 |
118 | Poor head control (HP:0002421) | 1.94387084 |
119 | Cutaneous melanoma (HP:0012056) | 1.94085306 |
120 | Metaphyseal dysplasia (HP:0100255) | 1.93567172 |
121 | Thyroiditis (HP:0100646) | 1.93285122 |
122 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92800443 |
123 | Keratoconjunctivitis sicca (HP:0001097) | 1.92248943 |
124 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90605659 |
125 | Hypothermia (HP:0002045) | 1.90196539 |
126 | Abnormality of eosinophils (HP:0001879) | 1.89822361 |
127 | Meningitis (HP:0001287) | 1.88807888 |
128 | Albinism (HP:0001022) | 1.87847820 |
129 | Nephronophthisis (HP:0000090) | 1.86030911 |
130 | Wormian bones (HP:0002645) | 1.85758531 |
131 | Granulocytopenia (HP:0001913) | 1.85137729 |
132 | Dysostosis multiplex (HP:0000943) | 1.84942610 |
133 | Aortic valve stenosis (HP:0001650) | 1.84810461 |
134 | Hypochromic microcytic anemia (HP:0004840) | 1.84443898 |
135 | Abnormality of the pericardium (HP:0001697) | 1.83621768 |
136 | Premature rupture of membranes (HP:0001788) | 1.83565803 |
137 | Alveolar cell carcinoma (HP:0006519) | 1.83511379 |
138 | Micronodular cirrhosis (HP:0001413) | 1.83232582 |
139 | Urticaria (HP:0001025) | 1.82343403 |
140 | Mucopolysacchariduria (HP:0008155) | 1.82028496 |
141 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82028496 |
142 | Joint swelling (HP:0001386) | 1.81924897 |
143 | Recurrent bronchitis (HP:0002837) | 1.80764526 |
144 | Autoimmune hemolytic anemia (HP:0001890) | 1.79971092 |
145 | Recurrent sinusitis (HP:0011108) | 1.79709176 |
146 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.79337178 |
147 | Joint hemorrhage (HP:0005261) | 1.79100765 |
148 | Exertional dyspnea (HP:0002875) | 1.78851955 |
149 | Molar tooth sign on MRI (HP:0002419) | 1.78486921 |
150 | Abnormality of midbrain morphology (HP:0002418) | 1.78486921 |
151 | Tetraparesis (HP:0002273) | 1.78347602 |
152 | Thyroid-stimulating hormone excess (HP:0002925) | 1.78008055 |
153 | Abnormal pupillary function (HP:0007686) | 1.77510737 |
154 | Poikilocytosis (HP:0004447) | 1.77472746 |
155 | Glomerulopathy (HP:0100820) | 1.77131573 |
156 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76569832 |
157 | Disproportionate short-trunk short stature (HP:0003521) | 1.76032580 |
158 | Purpura (HP:0000979) | 1.75800807 |
159 | Chronic otitis media (HP:0000389) | 1.74784001 |
160 | Abnormality of the pleura (HP:0002103) | 1.73655902 |
161 | Thrombophlebitis (HP:0004418) | 1.72543594 |
162 | Hypergammaglobulinemia (HP:0010702) | 1.72183438 |
163 | Heterochromia iridis (HP:0001100) | 1.71966073 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERBB3 | 4.06787450 |
2 | MAP3K14 | 3.78167086 |
3 | CDK19 | 3.33430106 |
4 | FRK | 2.99666290 |
5 | BLK | 2.68729302 |
6 | MAP4K2 | 2.57444434 |
7 | TBK1 | 2.55117791 |
8 | NEK9 | 2.52777473 |
9 | KIT | 2.41218903 |
10 | PBK | 2.14703547 |
11 | IRAK4 | 2.13874531 |
12 | EPHA3 | 2.11803264 |
13 | JAK3 | 1.94822773 |
14 | TGFBR2 | 1.92009854 |
15 | PIM2 | 1.89432279 |
16 | RIPK4 | 1.83596695 |
17 | TYK2 | 1.78986908 |
18 | NUAK1 | 1.73922316 |
19 | FES | 1.64614927 |
20 | ADRBK2 | 1.58054407 |
21 | BMPR2 | 1.57923509 |
22 | TGFBR1 | 1.56642386 |
23 | PINK1 | 1.53124153 |
24 | IKBKB | 1.51754113 |
25 | YES1 | 1.50670343 |
26 | IKBKE | 1.50221957 |
27 | CHUK | 1.49037050 |
28 | FGFR3 | 1.46336748 |
29 | MYLK | 1.45444657 |
30 | TESK1 | 1.44139698 |
31 | JAK1 | 1.42737208 |
32 | RIPK1 | 1.41998607 |
33 | SIK3 | 1.40526094 |
34 | CSF1R | 1.40385076 |
35 | TRPM7 | 1.37854348 |
36 | TNK2 | 1.37171423 |
37 | ERN1 | 1.36077005 |
38 | TEC | 1.35965417 |
39 | TRIM28 | 1.35784297 |
40 | FGR | 1.30435646 |
41 | BMPR1B | 1.28549276 |
42 | TXK | 1.27772008 |
43 | EIF2AK2 | 1.23842861 |
44 | MAP3K12 | 1.23832398 |
45 | WNK3 | 1.23587319 |
46 | GRK6 | 1.22459273 |
47 | SCYL2 | 1.20689536 |
48 | CSNK1G3 | 1.16704927 |
49 | RPS6KA4 | 1.16494882 |
50 | ITK | 1.13662388 |
51 | ZAK | 1.08566197 |
52 | BCKDK | 1.08378717 |
53 | SYK | 1.06539208 |
54 | TIE1 | 1.06170998 |
55 | PLK2 | 1.04263741 |
56 | CSNK1G2 | 1.04057386 |
57 | PIK3CG | 1.03172110 |
58 | MAPK13 | 1.02412220 |
59 | EPHB2 | 0.99648147 |
60 | ABL2 | 0.97447906 |
61 | CSNK1G1 | 0.93954251 |
62 | ZAP70 | 0.93494896 |
63 | IRAK3 | 0.92120355 |
64 | BTK | 0.91879836 |
65 | MATK | 0.91112260 |
66 | TRIB3 | 0.90392164 |
67 | ACVR1B | 0.90111541 |
68 | CDK6 | 0.89849086 |
69 | LYN | 0.88744341 |
70 | MST4 | 0.84920046 |
71 | LRRK2 | 0.83860352 |
72 | LIMK1 | 0.83405822 |
73 | GRK7 | 0.81952958 |
74 | GRK5 | 0.78705685 |
75 | CAMKK2 | 0.78029541 |
76 | DYRK3 | 0.77829129 |
77 | PTK6 | 0.76474969 |
78 | DAPK2 | 0.73629358 |
79 | EIF2AK1 | 0.72850920 |
80 | CSNK1A1L | 0.72160771 |
81 | PIK3CA | 0.71619024 |
82 | PDGFRA | 0.71342833 |
83 | BMX | 0.71217655 |
84 | MAP4K1 | 0.68812920 |
85 | TNIK | 0.68777068 |
86 | FLT3 | 0.68316425 |
87 | DDR2 | 0.68235901 |
88 | PRKCQ | 0.65954345 |
89 | PRKCD | 0.63972672 |
90 | JAK2 | 0.63649223 |
91 | MKNK1 | 0.63388702 |
92 | ERBB4 | 0.63064824 |
93 | PIM1 | 0.61645124 |
94 | CDK8 | 0.60242671 |
95 | MAP3K5 | 0.58780746 |
96 | ABL1 | 0.58749416 |
97 | HCK | 0.57667447 |
98 | RPS6KA6 | 0.57561772 |
99 | GRK1 | 0.57513277 |
100 | STK3 | 0.57154791 |
101 | FER | 0.57060075 |
102 | BCR | 0.56420375 |
103 | BRSK2 | 0.56178216 |
104 | PAK4 | 0.56051793 |
105 | EIF2AK3 | 0.56047042 |
106 | MAP3K4 | 0.55675926 |
107 | CAMK1D | 0.55310797 |
108 | VRK1 | 0.55149317 |
109 | DYRK2 | 0.55048310 |
110 | CSK | 0.54745888 |
111 | IGF1R | 0.54182608 |
112 | TAOK2 | 0.53842924 |
113 | TTN | 0.52175191 |
114 | LCK | 0.51812580 |
115 | ADRBK1 | 0.51095688 |
116 | NME2 | 0.49242702 |
117 | MAPKAPK2 | 0.48783749 |
118 | RPS6KA2 | 0.48443684 |
119 | FGFR4 | 0.47226995 |
120 | MAP2K3 | 0.46522036 |
121 | MST1R | 0.46408516 |
122 | PTK2B | 0.45871099 |
123 | FYN | 0.45619043 |
124 | ILK | 0.44529802 |
125 | PRKG2 | 0.43798192 |
126 | NLK | 0.43794722 |
127 | CCNB1 | 0.43513764 |
128 | TAOK3 | 0.43272877 |
129 | EGFR | 0.42587050 |
130 | DYRK1B | 0.41982558 |
131 | OXSR1 | 0.41958312 |
132 | RPS6KB1 | 0.41480701 |
133 | MAP2K7 | 0.41253025 |
134 | PRKG1 | 0.40913114 |
135 | KDR | 0.40593069 |
136 | MAPK7 | 0.40480030 |
137 | PRKCE | 0.40092447 |
138 | IRAK1 | 0.39720134 |
139 | RPS6KL1 | 0.38821203 |
140 | RPS6KC1 | 0.38821203 |
141 | PRKACG | 0.37440844 |
142 | PKN1 | 0.37207264 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.13407915 |
2 | Legionellosis_Homo sapiens_hsa05134 | 2.81187468 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.59670814 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58188420 |
5 | Malaria_Homo sapiens_hsa05144 | 2.48534136 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45190256 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.42410964 |
8 | Pertussis_Homo sapiens_hsa05133 | 2.32370674 |
9 | Phagosome_Homo sapiens_hsa04145 | 2.09166078 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02586356 |
11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.99648986 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.98322554 |
13 | Measles_Homo sapiens_hsa05162 | 1.97621534 |
14 | Tuberculosis_Homo sapiens_hsa05152 | 1.95285599 |
15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.87492663 |
16 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.83876249 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79249887 |
18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79087444 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78260757 |
20 | Salmonella infection_Homo sapiens_hsa05132 | 1.76595140 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74404056 |
22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69776123 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68577565 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.61856086 |
25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.60022900 |
26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.58205360 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57925136 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.57821421 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.57591345 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46700855 |
31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46060691 |
32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43622126 |
33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42769257 |
34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41445790 |
35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41198985 |
36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.39080864 |
37 | Apoptosis_Homo sapiens_hsa04210 | 1.36880540 |
38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34615984 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.33553655 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32294119 |
41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28785398 |
42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24591165 |
43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24203887 |
44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24136483 |
45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23057139 |
46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21752453 |
47 | Amoebiasis_Homo sapiens_hsa05146 | 1.21312271 |
48 | Asthma_Homo sapiens_hsa05310 | 1.20063355 |
49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18964838 |
50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17300954 |
51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16153763 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13070234 |
53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08531561 |
54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08454109 |
55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06576225 |
56 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02056637 |
57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99560988 |
58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94715806 |
59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93790464 |
60 | Platelet activation_Homo sapiens_hsa04611 | 0.92298864 |
61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92189630 |
62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91922372 |
63 | Focal adhesion_Homo sapiens_hsa04510 | 0.89226690 |
64 | Phototransduction_Homo sapiens_hsa04744 | 0.88388752 |
65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88386216 |
66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86594770 |
67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85085167 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.82866248 |
69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81617381 |
70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81602415 |
71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81475388 |
72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80516074 |
73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80492358 |
74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80357959 |
75 | Adherens junction_Homo sapiens_hsa04520 | 0.76449174 |
76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75644966 |
77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75462613 |
78 | Protein export_Homo sapiens_hsa03060 | 0.74504995 |
79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72327473 |
80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71261055 |
81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70123199 |
82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67462714 |
83 | Peroxisome_Homo sapiens_hsa04146 | 0.65425324 |
84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65244784 |
85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.64877287 |
86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61966933 |
87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60589099 |
88 | Salivary secretion_Homo sapiens_hsa04970 | 0.60004216 |
89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57909238 |
90 | Prion diseases_Homo sapiens_hsa05020 | 0.57214740 |
91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56750554 |
92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56629045 |
93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56164333 |
94 | Renin secretion_Homo sapiens_hsa04924 | 0.56036647 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56031644 |
96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55945951 |
97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54886819 |
98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53991842 |
99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53957894 |
100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53676000 |
101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53166997 |
102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52380729 |
103 | Long-term depression_Homo sapiens_hsa04730 | 0.52276148 |
104 | Melanoma_Homo sapiens_hsa05218 | 0.51673588 |
105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51600960 |
106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50606780 |
107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50007157 |
108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49848463 |
109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49548700 |
110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49239684 |
111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48888850 |
112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48518426 |
113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48216864 |
114 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47209799 |
115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46611284 |
116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46575347 |
117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.46480447 |
118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45359650 |
119 | Prostate cancer_Homo sapiens_hsa05215 | 0.44475619 |
120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43362656 |
121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43092778 |
122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42877679 |
123 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42641551 |
124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39538594 |
125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39463285 |
126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37177640 |
127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36685002 |
128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35944439 |
129 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35820893 |
130 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33252680 |
131 | Gap junction_Homo sapiens_hsa04540 | 0.33022616 |
132 | Endocytosis_Homo sapiens_hsa04144 | 0.32890363 |
133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31546514 |
134 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31529287 |
135 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31397562 |
136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30271210 |
137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29699980 |
138 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28973017 |
139 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28608589 |
140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28474097 |
141 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27316192 |
142 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27280229 |
143 | Glioma_Homo sapiens_hsa05214 | 0.26252457 |
144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24233908 |
145 | Insulin resistance_Homo sapiens_hsa04931 | 0.23854451 |